Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 11;39(1):80.
doi: 10.1007/s00383-022-05341-6.

The effect of hepatocyte growth factor on intestinal adaption in an experimental model of short bowel syndrome

George Bagias  1 , Evangelos P Misiakos  2 , Anestis Charalampopoulos  2 , Nick Zavras  2 , Stratigoula Sakellariou  3 , Dimitrios Schizas  4 , Igor Sukhotnik  5 , Evangelos Giamarelos  6 , Emmanouil Pikoulis  2
Affiliations

The effect of hepatocyte growth factor on intestinal adaption in an experimental model of short bowel syndrome

George Bagias et al. Pediatr Surg Int. .

Abstract

Purpose: Nowadays, the standard therapy for patients with short bowel syndrome is parenteral nutrition (PN). Various growth factors have been tested to achieve weaning from prolonged PN administration. We evaluated the effect of hepatocyte growth factor (HGF) on structural intestinal adaptation and cell proliferation in a rat model of SBS.

Methods: Thirty Sprague-Dawley rats were divided into three groups; group A rats (sham) underwent bowel transection, group B rats underwent a 75% bowel resection, and group C rats underwent the same procedure but were treated postoperatively with HGF. Histopathologic parameters of intestinal adaptation were determined, while microarray and rt-PCR analyses of ileal RNA were also performed.

Results: Treatment with HGF resulted in significant increase in body weight, while the jejunal and ileal villus height and crypt depth were increased in HGF rats (36%, p < 0.05 and 27%, p < 0.05 respectively). Enterocyte proliferation was also significantly increased in HGF rats (21% p < 0.05). Microarray and quantitative rt-PCR analyses showed that the genes hgfac, rac 1, cdc42, and akt 1 were more than twofold up-regulated after HGF treatment.

Conclusion: HGF emerges as a growth factor that enhances intestinal adaptation. The future use of HGF may potentially reduce the requirement for PN in SBS patients.

Keywords: Cell proliferation; Gene up-regulation; Hepatocyte growth factor; Intestinal adaptation; Short bowel syndrome.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Duggan CP, Jaksic T (2017) Pediatric Intestinal Failure. N Engl J Med 377:666–675. https://doi.org/10.1056/NEJMra1602650 - DOI - PubMed
    1. Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O’keefe SJ, et al (2012) Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 143:1473–81.e3. https://doi.org/10.1053/j.gastro.2012.09.007 - DOI - PubMed
    1. Ukleja A (2019) Weaning from Parenteral Nutrition. Gastroenterol Clin North Am 48:525–550. https://doi.org/10.1016/j.gtc.2019.08.007 - DOI - PubMed
    1. McMellen ME, Wakeman D, Longshore SW, McDuffie LA, Warner BW (2010) Growth factors: possible roles for clinical management of the short bowel syndrome. Semin Pediatr Surg 19:35–43. https://doi.org/10.1053/j.sempedsurg.2009.11.010 - DOI - PubMed - PMC
    1. Billiauws L, Joly F (2019) Emerging treatments for short bowel syndrome in adult patients. Expert Rev Gastroenterol Hepatol 13:241–246. https://doi.org/10.1080/17474124.2019.1569514 - DOI - PubMed

Substances

LinkOut - more resources